结合常规治疗的特利塔西塞普成功治疗了与MDA5相关的RPILD:一个病例报告
Lang Zhang1,2, Yuhan Luo1,2, Xingqin Shao1,2
1Zunyi Medical University, Zunyi City, Guizhou Province, China.
Medicine
|July 15, 2025
概括
这项案例研究表明,一种新的组合疗法,包括tlitacicept,成功治疗了一名患有黑色素瘤分化相关基因5 (MDA5) 相关的快速进展性间歇性肺病 (RPILD) 的患者. 这种方法改善了肺功能和炎症,为这种罕见的疾病提供了希望.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 与黑色素瘤分化相关的基因5 (MDA5) 相关的快速进展性间歇性肺病 (RPILD) 是一种严重的,罕见的疾病,缺乏标准治疗方法.
- 目前对MDA5相关的RPILD的治疗选择有限,需要探索新的治疗策略.
研究的目的:
- 报告一个成功治疗MDA5相关RPILD的病例,使用一种新型组合疗法.
- 为了评估telitacicept与标准免疫抑制剂结合用于MDA5相关RPILD的疗效.
主要方法:
- 一名69岁的女性患者,根据临床表现,成像和自身抗体分析,诊断出MDA5相关的RPILD.
- 治疗包括高剂量的甲基前尼索隆脉冲疗法,环胺和新型TACI-Fc融合蛋白的telitacicept.
主要成果:
- 治疗后氧化指数显著改善,从174毫米升至306毫米升.
- 在后续的胸部CT扫描中,双边肺炎几乎完全消失.
- 肺功能测试显示有改善,6个月后一氧化碳的扩散能力达到预测值的63.6%.
结论:
- 结合疗法,包括特利塔cept显示承诺作为一个有效的治疗MDA5相关的RPILD.
- 需要进一步的研究来验证这些发现,并理解telitacicept在这种情况下的治疗机制.
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


